Get the Stockscreener App
172.38
1.06%
-1.736
Overview
News
Price History
Option Chain
Financials
Why ZTS Down?
Discussions
Forecast
Dividend History
Zoetis Inc stock is traded at $172.38, with a volume of 609.29K.
It is down -1.06% in the last 24 hours and up +5.38% over the past month.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
See More
Previous Close:
$174.12
Open:
$174.22
24h Volume:
609.29K
Relative Volume:
0.25
Market Cap:
$78.56B
Revenue:
$9.15B
Net Income/Loss:
$2.43B
P/E Ratio:
32.40
EPS:
5.32
Net Cash Flow:
$2.31B
1W Performance:
+0.81%
1M Performance:
+5.38%
6M Performance:
-6.76%
1Y Performance:
-12.59%
1-Day Range:
$172.04
$175.50
1-Week Range:
$168.28
$177.40
52-Week Range:
$144.80
$200.53
Zoetis Inc Stock (ZTS) Company Profile
Compare ZTS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ZTS
Zoetis Inc
|
172.24 | 78.56B | 9.15B | 2.43B | 2.31B | 5.32 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.57 | 43.15B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
9.555 | 43.00B | 14.26B | 1.55B | 0 | 0.3383 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.82 | 19.59B | 16.54B | -1.64B | 749.00M | -1.45 |
|
NBIX
Neurocrine Biosciences Inc
|
123.67 | 15.24B | 2.24B | 385.90M | 440.10M | 3.73 |
Zoetis Inc Stock (ZTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-24 | Initiated | Leerink Partners | Outperform |
| Jul-25-24 | Initiated | BTIG Research | Buy |
| Jan-12-24 | Reiterated | Stifel | Buy |
| Dec-19-23 | Resumed | Jefferies | Buy |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Jul-12-22 | Initiated | Piper Sandler | Overweight |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-16-21 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Mar-08-21 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-08-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Sep-21-20 | Initiated | Atlantic Equities | Overweight |
| Aug-14-20 | Upgrade | Edward Jones | Hold → Buy |
| Aug-12-20 | Downgrade | Gabelli & Co | Buy → Hold |
| May-27-20 | Initiated | Jefferies | Buy |
| Jan-10-20 | Initiated | Raymond James | Mkt Perform |
| Sep-09-19 | Initiated | Goldman | Buy |
| Jul-01-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jun-11-19 | Initiated | Barclays | Overweight |
| May-23-19 | Initiated | Guggenheim | Buy |
| May-03-19 | Downgrade | Gabelli & Co | Buy → Hold |
| Mar-20-19 | Initiated | SunTrust | Hold |
| Mar-04-19 | Upgrade | Stifel | Hold → Buy |
| Jan-23-19 | Initiated | UBS | Neutral |
| Oct-15-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Aug-22-18 | Downgrade | Stifel | Buy → Hold |
| Aug-03-18 | Reiterated | Stifel | Buy |
| Apr-19-18 | Reiterated | Citigroup | Buy |
| Mar-19-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Feb-16-18 | Reiterated | Stifel | Buy |
| Jan-04-18 | Upgrade | Citigroup | Neutral → Buy |
View All
Zoetis Inc Stock (ZTS) Latest News
Telos Capital Management Inc. Acquires 1,776 Shares of Zoetis Inc. (NYSE:ZTS) - MarketBeat
Zoetis (NYSE:ZTS) Has A Pretty Healthy Balance Sheet - Yahoo Finance
State of Alaska Department of Revenue Trims Position in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Tyche Wealth Partners LLC Buys New Position in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Mirae Asset Global Investments Co. Ltd. Grows Stock Position in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Phibro raises FY 2025 guidance with Zoetis portfolio integration driving 25% revenue growth - MSN
Zoetis Inc. (NYSE:ZTS) Stock Position Increased by Calamos Wealth Management LLC - MarketBeat
Spire Wealth Management Decreases Stock Position in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Alliance Wealth Advisors LLC UT Buys 3,700 Shares of Zoetis Inc. (NYSE:ZTS) - MarketBeat
Zoetis sets $0.50 per share dividend for Q2 2025 - MSN
William Blair Issues Negative Estimate for Zoetis Earnings - MarketBeat
Opportunities to Improve Chick Health: Interview with Tarsicio Villalobos from Zoetis at IPPE 2025 - aviNews International
Zoetis Announces Q2 2025 Dividend Payment - TipRanks
Zoetis sets $0.50 per share dividend for Q2 2025 By Investing.com - Investing.com South Africa
Zoetis Declares Second Quarter 2025 Dividend - The Bakersfield Californian
ZTS: 3 Pet Industry Stocks Profiting from Animal Lovers - StockNews.com
Veterinary Wound Cleansers Market Share & Growth Forecast - GlobeNewswire
Veterinary Wound Cleansers Market Share & Growth Forecast Report 2025-2030, with Elanco, Vetoquinol, Virbac, Innovacyn, Axio Biosolutions, Neogen, Pet Natural Remedies, Zoetis and More - Yahoo Finance
Zoetis (ZTS) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
Legacy CG LLC Buys New Stake in Zoetis Inc. (NYSE:ZTS) - MarketBeat
YANKCOM Partnership Purchases Shares of 2,904 Zoetis Inc. (NYSE:ZTS) - MarketBeat
Zoetis Inc. (NYSE:ZTS) Stock Holdings Increased by Choreo LLC - MarketBeat
Yousif Capital Management LLC Sells 3,137 Shares of Zoetis Inc. (NYSE:ZTS) - MarketBeat
Stock Yards Bank & Trust Co. Sells 2,021 Shares of Zoetis Inc. (NYSE:ZTS) - MarketBeat
Animal Parasiticides Market Witness Growth: Size, Share, - openPR
Librela™ update: Changes to Librela label from Zoetis - AAHA
Zoetis Inc. stock outperforms competitors on strong trading day - MarketWatch
Nvwm LLC Grows Stock Holdings in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Pet Vaccines Market Growth to Accelerate in Forecast Period - openPR
Avitas Wealth Management LLC Buys 6,828 Shares of Zoetis Inc. (NYSE:ZTS) - MarketBeat
Windward Capital Management Co. CA Lowers Position in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Ninety One UK Ltd Raises Holdings in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Zoetis Inc. (NYSE:ZTS) Shares Sold by Boston Trust Walden Corp - MarketBeat
Zoetis Inc. (NYSE:ZTS) Shares Sold by Tritonpoint Wealth LLC - MarketBeat
Zoetis announces updated label for Librela - TipRanks
Zoetis Announces U.S. Label Update for Librela® (bedinvetmab injection), a Treatment to Control Canine Osteoarthritis (OA) Pain - Vet Candy
Updated Zoetis label for Librela ‘a relief,’ says Piper Sandler - MSN
Zoetis Adds Warnings to Label for Dog Pain Drug - MSN
Zoetis updates Librela label after post-approval data - MSN
Zoetis Inc. (NYSE:ZTS) Holdings Lifted by E. Ohman J or Asset Management AB - MarketBeat
Zoetis Updates Label on Drug for Treatment of Canine Osteoarthritis -February 04, 2025 at 08:48 am EST - Marketscreener.com
Zoetis Inc. (NYSE:ZTS) Shares Acquired by Calamos Advisors LLC - MarketBeat
Zoetis updates Librela label after post-approval data By Investing.com - Investing.com UK
(bedinvetmab injection), a Treatment to Control Canine Osteoarthritis (OA) Pain - Business Wire
abrdn plc Cuts Stock Holdings in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Cibc World Market Inc. Purchases 49,774 Shares of Zoetis Inc. (NYSE:ZTS) - MarketBeat
Institute for Wealth Management LLC. Has $330,000 Stock Holdings in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Sivik Global Healthcare LLC Buys New Shares in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Turtle Creek Wealth Advisors LLC Decreases Stock Holdings in Zoetis Inc. (NYSE:ZTS) - MarketBeat
SteelPeak Wealth LLC Takes Position in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Stifel maintains Zoetis stock Buy rating, $180 target amid Librela view - MSN
Zoetis Inc Stock (ZTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.37%
0.26%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):